Agrin Binds α-synuclein and Modulates α-synuclein Fibrillation

Document Type

Article

Publication Date

2005

Keywords

Agrin, Heparan Sulfate Proteoglycan, Parkinson’s Disease, Protein Conformational Disorders, α-synuclein

Digital Object Identifier (DOI)

https://doi.org/10.1093/glycob/cwj014

Abstract

Recent studies have begun to investigate the role of agrin in brain and suggest that agrin’s function likely extends beyond that of a synaptogenic protein. Particularly, it has been shown that agrin is associated with the pathological lesions of Alzheimer’s disease (AD) and may contribute to the formation of β-amyloid (Aβ) plaques in AD. We have extended the analysis of agrin’s function in neurodegenerative diseases to investigate its role in Parkinson’s disease (PD). α-Synuclein is a critical molecular determinant in familial and sporadic PD, with the formation of α-synuclein fibrils being enhanced by sulfated macromolecules. In the studies reported here, we show that agrin binds to α-synuclein in a heparan sulfate-dependent (HS-dependent) manner, induces conformational changes in this protein characterized by β-sheet structure, and enhances insolubility of α-synuclein. We also show that agrin accelerates the formation of protofibrils by α-synuclein and decreases the half-time of fibril formation. The association of agrin with PD lesions was also explored in PD human brain, and these studies shown that agrin colocalizes with α-synuclein in neuronal Lewy bodies in the substantia nigra of PD brain. These studies indicate that agrin is capable of accelerating the formation of insoluble protein fibrils in a second common neurodegenerative disease. These findings may indicate shared molecular mechanisms leading to the pathophysiology in these two neurodegenerative disorders.

Was this content written or created while at USF?

Yes

Citation / Publisher Attribution

Glycobiology, v. 15, issue 12, p. 1320-1331

Link to Full Text

Share

COinS